𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prediction of sustained response to low-dose pegylated interferon alpha-2b plus ribavirin in patients with genotype 1b and high hepatitis C virus level using viral reduction within 2 weeks after therapy initiation

✍ Scribed by Hideyuki Tamai; Naoki Shingaki; Tatsuya Shiraki; Hiroshi Tukuda; Yoshiyuki Mori; Kosaku Moribata; Shotaro Enomoto; Hisanobu Deguchi; Kazuki Ueda; Izumi Inoue; Takao Maekita; Mikitaka Iguchi; Kimihiko Yanaoka; Masashi Oka; Masao Ichinose


Book ID
118088471
Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
107 KB
Volume
41
Category
Article
ISSN
1386-6346

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Efficacy of low-dose intermittent interf
✍ Norio Akuta; Fumitaka Suzuki; Yusuke Kawamura; Hiromi Yatsuji; Hitomi Sezaki; Yo πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 128 KB πŸ‘ 2 views

## Abstract The efficacy of interferon (IFN) monotherapy for non‐responders to pegylated interferon (PEG‐IFN) plus ribavirin (RBV) combination therapy is still unclear. To evaluate the impact of IFN monotherapy on biochemical response, 200 consecutive patients infected with HCV genotype 1b, who rec